当前位置:首页 - 行情中心 - 新华制药(000756) - 财务分析 - 资产负债表

新华制药

(000756)

  

流通市值:70.49亿  总市值:98.44亿
流通股本:4.99亿   总股本:6.97亿

资产负债表

报告期2026-03-312025-12-312025-09-302025-06-30
公司类型通用通用通用通用
流动资产:
  货币资金1,276,588,267.771,396,482,926.221,234,429,753.941,275,011,109.26
  应收票据及应收账款1,130,405,454.59889,236,049.961,059,519,078.731,136,819,266.53
  其中:应收票据16,916,389.1926,847,465.7638,371,015.9240,854,404.7
        应收账款1,113,489,065.4862,388,584.21,021,148,062.811,095,964,861.83
  应收款项融资292,318,314.4319,240,231.72225,054,822.49240,664,014.73
  预付款项63,619,980.5545,125,129.8766,471,212.1348,729,404.72
  其他应收款合计11,287,643.97,978,709.3510,232,414.8917,937,300.7
        应收股利---5,400,000
  存货1,215,750,772.881,318,099,539.031,252,463,607.931,228,936,025.5
  合同资产212,662.81427,899.59286,277.52286,277.52
  其他流动资产61,626,905.8156,882,119.7250,326,681.1643,703,252.04
  流动资产合计4,051,810,002.714,033,472,605.463,898,783,848.793,992,086,651
非流动资产:
  长期股权投资58,524,627.4558,191,097.5657,813,954.657,590,319.83
  其他权益工具投资253,923,303.48280,078,103.48242,835,399.48265,305,975.48
  投资性房地产28,895,161.5629,714,671.9329,386,667.7130,213,992.72
  固定资产3,679,115,742.713,783,252,309.593,703,932,675.033,542,376,410.38
  在建工程381,696,792.17366,170,853.13497,051,642.08695,988,166.39
  使用权资产2,644,415.82,364,683.52,902,241.543,159,011.69
  无形资产557,539,391.17577,399,466.6561,659,224.91542,570,073.69
  开发支出14,603,773.69,764,150.959,764,150.957,075,471.7
  长期待摊费用5,411,572.325,995,928.716,638,022.987,693,919.94
  递延所得税资产16,836,682.121,190,510.5515,543,218.518,278,099.87
  其他非流动资产17,926,486.718,101,386.767,429,081.4575,315,694.63
  非流动资产合计5,017,117,949.065,152,223,162.75,194,956,279.235,245,567,136.32
  资产总计9,068,927,951.779,185,695,768.169,093,740,128.029,237,653,787.32
流动负债:
  短期借款454,764,443.91433,638,538.34513,508,096.71252,925,995.11
  应付票据及应付账款1,230,076,979.241,311,118,732.861,294,735,923.021,321,094,611.92
  其中:应付票据518,161,357.9525,783,642.79551,331,641.88534,481,204.4
        应付账款711,915,621.34785,335,090.07743,404,281.14786,613,407.52
  合同负债85,984,949.52149,301,833.2976,034,891.2759,783,672.7
  应付职工薪酬47,348,169.5464,892,697.3436,985,138.235,889,415.31
  应交税费37,804,571.6124,120,526.4727,608,330.6233,404,035.88
  其他应付款合计395,930,269.23437,385,479.24487,994,710.21708,332,192.2
        应付股利5,310,599.535,310,599.535,310,599.53177,754,733.28
  一年内到期的非流动负债23,253,831.1352,157,956.11508,375,185.86706,316,828.87
  其他流动负债21,600,617.3938,586,676.1137,112,442.9434,446,293.89
  流动负债合计2,296,763,831.542,811,202,439.762,982,354,718.833,152,193,045.88
非流动负债:
  长期借款942,319,527.08695,319,527.08498,319,527.08490,319,527.08
  租赁负债730,732.99744,839.51,032,045.281,432,596.27
  长期应付款24,500,00024,500,00024,500,00023,500,000
  递延收益65,054,504.6368,970,978.5873,363,014.6977,755,960.85
  递延所得税负债140,136,345.55125,669,980120,214,616.23123,898,631.67
  其他非流动负债3,561,5003,561,5003,561,5003,561,500
  非流动负债合计1,176,302,610.25918,766,825.16720,990,703.28720,468,215.87
  负债合计3,473,066,441.793,729,969,264.923,703,345,422.113,872,661,261.75
所有者权益(或股东权益):
  实收资本(或股本)696,683,435689,776,535689,776,535689,776,535
  资本公积1,275,364,511.781,204,650,327.111,205,809,440.871,199,765,410.64
  其他综合收益172,523,029.74195,957,428.58164,743,661.62184,250,475.27
  专项储备15,107,752.812,163,037.8216,160,215.8912,877,284.97
  盈余公积459,449,822.02459,449,822.02438,326,844.39438,326,844.39
  未分配利润2,730,659,138.352,646,756,093.992,634,210,926.742,601,746,747.05
  归属于母公司股东权益合计5,349,787,689.695,208,753,244.525,149,027,624.515,126,743,297.32
  少数股东权益246,073,820.29246,973,258.72241,367,081.4238,249,228.25
  股东权益合计5,595,861,509.985,455,726,503.245,390,394,705.915,364,992,525.57
  负债和股东权益合计9,068,927,951.779,185,695,768.169,093,740,128.029,237,653,787.32
公告日期2026-04-292026-03-302025-10-252025-08-27
审计意见(境内)标准无保留意见
TOP↑